Daniel Delaney is an experienced executive in the healthcare and biotechnology sectors, currently serving as President & CEO of TECHLAB, Inc. and a member of the board of directors at both RhythMedix and Absolute Biotech. Previously, Daniel held the position of HealthCare Operating Executive at Pharos Capital Group and served as President of Viracor-IBT Laboratories, Inc. Daniel holds a Bachelor of Arts degree in Business and Economics from Baruch College and also attended Saint Anselm College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices